BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cui W, Wang Y, Fan W, Lu M, Zhang Y, Yao W, Li J. Comparison of intraluminal radiofrequency ablation and stents vs. stents alone in the management of malignant biliary obstruction. Int J Hyperthermia 2017;33:853-61. [PMID: 28540797 DOI: 10.1080/02656736.2017.1309580] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Yildirim G, Karakas HM. Efficacy and safety of percutaneous endobilliary radiofrequency ablation with a novel temperature-controlled catheter in malignant biliary strictures. Pol J Radiol 2022;87:e487-93. [PMID: 36091648 DOI: 10.5114/pjr.2022.119218] [Reference Citation Analysis]
2 de Jong DM, Fritzsche JA, Audhoe AS, Yi SSL, Bruno MJ, Voermans RP, van Driel LMJW. Comparison of Intraductal RFA Plus Stent versus Stent-Only Treatment for Unresectable Perihilar Cholangiocarcinoma—A Systematic Review and Meta-Analysis. Cancers 2022;14:2079. [DOI: 10.3390/cancers14092079] [Reference Citation Analysis]
3 Park Y, Won D, Bae G, Ryu DS, Kang JM, Kim JW, Kim SH, Zeng CH, Park W, Lee SS, Park J. Silver Nanofunctionalized Stent after Radiofrequency Ablation Suppresses Tissue Hyperplasia and Bacterial Growth. Pharmaceutics 2022;14:412. [DOI: 10.3390/pharmaceutics14020412] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Hendriquez R, Keihanian T, Goyal J, Abraham RR, Mishra R, Girotra M. Radiofrequency ablation in the management of primary hepatic and biliary tumors. World J Gastrointest Oncol 2022; 14(1): 203-215 [DOI: 10.4251/wjgo.v14.i1.203] [Reference Citation Analysis]
5 Zhang T, Zhang S, Jin C, Lin Z, Deng T, Xie X, Deng L, Li X, Ma J, Ding X, Liu Y, Shan Y, Yu Z, Wang Y, Chen G, Li J. A Predictive Model Based on the Gut Microbiota Improves the Diagnostic Effect in Patients With Cholangiocarcinoma. Front Cell Infect Microbiol 2021;11:751795. [PMID: 34888258 DOI: 10.3389/fcimb.2021.751795] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
6 Uyanık SA, Öğüşlü U, Çevik H, Atlı E, Yılmaz B, Gümüş B. Percutaneous endobiliary ablation of malignant biliary strictures with a novel temperature-controlled radiofrequency ablation device. Diagn Interv Radiol 2021;27:102-8. [PMID: 33252335 DOI: 10.5152/dir.2020.20333] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Gou Q, Wu L, Cui W, Mo Z, Zeng D, Gan L, He J, Mai Q, Shi F, Chen M, Sun Z, Liu Y, Wu J, Chen X, Zhuang W, Xu R, Li W, Cai Q, Zhang J, Chen X, Li J, Zhou Z. Stent placement combined with intraluminal radiofrequency ablation and hepatic arterial infusion chemotherapy for advanced biliary tract cancers with biliary obstruction: a multicentre, retrospective, controlled study. Eur Radiol 2021;31:5851-62. [PMID: 33585991 DOI: 10.1007/s00330-021-07716-0] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
8 Hamada T, Nakai Y, Isayama H. TOKYO criteria: Standardized reporting system for endoscopic biliary stent placement. Gastrointestinal Intervention 2018;7:46-51. [DOI: 10.18528/gii180016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
9 Acu B, Kurtulus Ozturk E. Feasibility and safety of percutaneous transhepatic endobiliary radiofrequency ablation as an adjunct to biliary stenting in malignant biliary obstruction. Diagnostic and Interventional Imaging 2018;99:237-45. [DOI: 10.1016/j.diii.2017.10.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]